A pharmaceutical study on some modified release solid dosage forms of certain statins / Balqees Saeed Ahmed Mohamed Hazaa ; Supervised Ahmed Abdelbary Abdelrahman , Howida Kamal Ibrahim
Material type:
- دراسة صيدلية على بعض الأشكال الصيدلية الصلبة محورة الإنطلاق لستاتينات معينة [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.08.M.Sc.2011.Ba.P (Browse shelf(Opens below)) | Not for loan | 01010110055816000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.08.M.Sc.2011.Ba.P (Browse shelf(Opens below)) | 55816.CD | Not for loan | 01020110055816000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.08.08.M.Sc.2011.Am.F Formulation and biopharmaceutical evaluation of medroxyprogesterone acetate in prolonged parenteral product / | Cai01.08.08.M.Sc.2011.Ay.F Formulation of sustained release drug delivery systems of metronidazole and amoxycullin / | Cai01.08.08.M.Sc.2011.Ay.F Formulation of sustained release drug delivery systems of metronidazole and amoxycullin / | Cai01.08.08.M.Sc.2011.Ba.P A pharmaceutical study on some modified release solid dosage forms of certain statins / | Cai01.08.08.M.Sc.2011.Ba.P A pharmaceutical study on some modified release solid dosage forms of certain statins / | Cai01.08.08.M.Sc.2011.Em.P A pharmaceutical study on pantoprazole / | Cai01.08.08.M.Sc.2011.Em.P A pharmaceutical study on pantoprazole / |
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Simvastatin is a potent inhibitor of 3- hydroxy - 3 - methy1 - glutary1 - coenzyme A ( HMG - CoA ) reductase and a cholesterol - lowering widely uaed to treat hypercholesterolemia . However, it gave poorly oral bioavailability ( < 5% ) due to its water - insolubility and extensive first pass metabolism by the CYP 450 isoform 3A4, and to a lesser degree, by CYP3A5, in the intestinal wall and liver
Issued also as CD
There are no comments on this title.